The combination targets blood sugar control from two angles: metformin reduces liver glucose production, while Ozempic suppresses appetite and enhances insulin secretion in response to meals
AOD-9604 Dosing Protocols Based on Clinical Research Dosing recommendations for AOD-9604 are based on extensive human research including six clinical trials that evaluated various administration routes, doses, and treatment durations
Kennedy, Cayman Chemical Company, United States Yunwei Han, The Affiliated Hospital of Southwest Medical University, China Updates Copyright 2024 Li, Meng, Wang, Sun, Chang, Li and Chen
Research interest includes neurochemical-pathway studies (serotonin and GABA modulation), learning and memory research models, and immunomodulation investigations